RE:RE:RE:RE:Too Soon eh!ya-ya..., I'd love to see such things happened, but, unfortunately, in my 12trading yrs I've seen so many "happy Guses" been slaughtered ed and I learned to be careful with my expectations...
gebremeskel wrote: What a couple of gloomy Guses! Yes there's been a delay but there's no reason to start talking about a reverse split or another financing yet - if at all. There will likely be a phase 1b trial for another indication in 2020 and there will be many more than 20 phase 2 NMIBC patients hitting the one year results mark in 2021. There's every reason to think the coming results will be stellar. So we've got a strong shot at accelerated approval in 2021.
Where do you think the stock price will be with an approved (and game-changing) treatment for NMIBC and trials for other cancer indications started?
medvic1 wrote: It is quite realistic view as for me. The last financing was terrible. I would say if general stock market will slide into recession, who knows what dip it can be, 0.60 - 0.70c is the most we can hope. Another financing is guaranteed and 1:10 split too, mark my words. BUT, BUT, those who holds and accumulate will win.
My story with CVM: hold about 50,000shares at 0.35c for many years,1:10 split come, after couple yers at Ph3 1:25 split again. So, I ended up buying 1500shares at $7.15 last year. Awaiting FDA approval now, if success - PS will jump over $100 - $200, if fail - $1.
So, if you believe in TLT - hold it and accumulate at funny price like it was at 0.16c. I'm done with TLT trading and my 60k shares locked, for now..., my average 0.27c.
nemo3 wrote: Yes, TLT is very frustrating. Besides being hammered by the halt of TLT's application to the FDA that took 6 months to iron out, we were also slammed by COVID-19 which caused a temporary cessation of the Phase 2 clinical trial. We don't know when new patients will be brought in and treated. And seems the patients treated so far may not get the second treatment at 6 months. It may be that all patients treated and making the 1 year mark post treatment might not be completed until 2022. I think the market has spoken that currently there is little confidence in TLT. I think given the way it currently trades, previous thoughts by some that this stock would reach $100 is but an unrealistic dream. I want to see 60 cents and then maybe if things all went well in 2021 or 2022 we could see TLT at a couple of bucks. Because with this delay TLT may well run out of money before the end of the current Ph 2 study and have to do another financing which will create far too many outstanding shares to create the value we are all waiting for. So I will continue to hold and hope that in the next year or so my frustration will be rewarded by at least 10 times the current value.